nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—ORM1—Vemurafenib—melanoma	0.168	0.284	CbGbCtD
Desipramine—ABCB1—melanoma	0.108	1	CbGaD
Desipramine—SLC22A5—Dactinomycin—melanoma	0.0969	0.164	CbGbCtD
Desipramine—CYP2E1—Dacarbazine—melanoma	0.0561	0.0948	CbGbCtD
Desipramine—CYP1A2—Carmustine—melanoma	0.0535	0.0905	CbGbCtD
Desipramine—CYP1A2—Vemurafenib—melanoma	0.0423	0.0715	CbGbCtD
Desipramine—CYP3A4—Temozolomide—melanoma	0.0405	0.0684	CbGbCtD
Desipramine—CYP2D6—Vemurafenib—melanoma	0.0349	0.0589	CbGbCtD
Desipramine—CYP1A2—Dacarbazine—melanoma	0.0324	0.0548	CbGbCtD
Desipramine—ABCB1—Dactinomycin—melanoma	0.0246	0.0416	CbGbCtD
Desipramine—CYP3A4—Vemurafenib—melanoma	0.0222	0.0375	CbGbCtD
Desipramine—ABCB1—Docetaxel—melanoma	0.0127	0.0215	CbGbCtD
Desipramine—CYP3A4—Docetaxel—melanoma	0.00761	0.0129	CbGbCtD
Desipramine—Raised liver function tests—Dactinomycin—melanoma	0.00251	0.0252	CcSEcCtD
Desipramine—Tongue discolouration—Temozolomide—melanoma	0.00217	0.0218	CcSEcCtD
Desipramine—Drug fever—Docetaxel—melanoma	0.00209	0.0209	CcSEcCtD
Desipramine—CHRM5—skin epidermis—melanoma	0.00168	0.106	CbGeAlD
Desipramine—Raised liver function tests—Docetaxel—melanoma	0.00151	0.0151	CcSEcCtD
Desipramine—Extrapyramidal disorder—Temozolomide—melanoma	0.00139	0.014	CcSEcCtD
Desipramine—Petechiae—Temozolomide—melanoma	0.00127	0.0128	CcSEcCtD
Desipramine—Eosinophilia—Vemurafenib—melanoma	0.00127	0.0128	CcSEcCtD
Desipramine—Neuropathy peripheral—Vemurafenib—melanoma	0.00112	0.0113	CcSEcCtD
Desipramine—Coordination abnormal—Carmustine—melanoma	0.0011	0.0111	CcSEcCtD
Desipramine—Coordination abnormal—Temozolomide—melanoma	0.00107	0.0107	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Temozolomide—melanoma	0.00105	0.0105	CcSEcCtD
Desipramine—Disorientation—Bleomycin—melanoma	0.00101	0.0101	CcSEcCtD
Desipramine—Benazepril—SLC15A2—melanoma	0.000984	0.346	CrCbGaD
Desipramine—Gynaecomastia—Carmustine—melanoma	0.00097	0.00973	CcSEcCtD
Desipramine—Cerebrovascular accident—Bleomycin—melanoma	0.00092	0.00923	CcSEcCtD
Desipramine—Alopecia—Vemurafenib—melanoma	0.000909	0.00913	CcSEcCtD
Desipramine—Dysgeusia—Vemurafenib—melanoma	0.000877	0.00881	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Temozolomide—melanoma	0.000874	0.00877	CcSEcCtD
Desipramine—Vascular purpura—Temozolomide—melanoma	0.00085	0.00853	CcSEcCtD
Desipramine—Purpura—Temozolomide—melanoma	0.000789	0.00792	CcSEcCtD
Desipramine—SMPD1—skin of body—melanoma	0.000782	0.0492	CbGeAlD
Desipramine—HTR2A—hindlimb—melanoma	0.000781	0.0491	CbGeAlD
Desipramine—Liver function test abnormal—Dactinomycin—melanoma	0.000776	0.00779	CcSEcCtD
Desipramine—Ataxia—Carmustine—melanoma	0.00074	0.00743	CcSEcCtD
Desipramine—Liver function test abnormal—Carmustine—melanoma	0.000726	0.00729	CcSEcCtD
Desipramine—Ataxia—Temozolomide—melanoma	0.000715	0.00718	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Docetaxel—melanoma	0.000697	0.00699	CcSEcCtD
Desipramine—Acute coronary syndrome—Bleomycin—melanoma	0.000685	0.00687	CcSEcCtD
Desipramine—Hypotension—Vemurafenib—melanoma	0.000683	0.00686	CcSEcCtD
Desipramine—Myocardial infarction—Bleomycin—melanoma	0.000681	0.00683	CcSEcCtD
Desipramine—Stomatitis—Bleomycin—melanoma	0.000677	0.0068	CcSEcCtD
Desipramine—HTR2A—appendage—melanoma	0.00067	0.0421	CbGeAlD
Desipramine—Decreased appetite—Vemurafenib—melanoma	0.000636	0.00638	CcSEcCtD
Desipramine—Stomatitis—Dactinomycin—melanoma	0.000631	0.00634	CcSEcCtD
Desipramine—Fatigue—Vemurafenib—melanoma	0.00063	0.00633	CcSEcCtD
Desipramine—Constipation—Vemurafenib—melanoma	0.000625	0.00628	CcSEcCtD
Desipramine—Lightheadedness—Docetaxel—melanoma	0.000623	0.00626	CcSEcCtD
Desipramine—Hypoaesthesia—Bleomycin—melanoma	0.00062	0.00623	CcSEcCtD
Desipramine—Pollakiuria—Temozolomide—melanoma	0.000607	0.00609	CcSEcCtD
Desipramine—Erectile dysfunction—Temozolomide—melanoma	0.000605	0.00607	CcSEcCtD
Desipramine—Depression—Carmustine—melanoma	0.000605	0.00607	CcSEcCtD
Desipramine—Agranulocytosis—Dactinomycin—melanoma	0.000605	0.00607	CcSEcCtD
Desipramine—CHRM5—eye—melanoma	0.000598	0.0376	CbGeAlD
Desipramine—Weight increased—Temozolomide—melanoma	0.000598	0.006	CcSEcCtD
Desipramine—Neuropathy peripheral—Carmustine—melanoma	0.000594	0.00597	CcSEcCtD
Desipramine—Stomatitis—Carmustine—melanoma	0.000591	0.00593	CcSEcCtD
Desipramine—Depression—Temozolomide—melanoma	0.000584	0.00586	CcSEcCtD
Desipramine—Hepatitis—Dactinomycin—melanoma	0.000582	0.00584	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.000581	0.00583	CcSEcCtD
Desipramine—CYP2C18—mammalian vulva—melanoma	0.00058	0.0365	CbGeAlD
Desipramine—Flushing—Bleomycin—melanoma	0.000579	0.00581	CcSEcCtD
Desipramine—Body temperature increased—Vemurafenib—melanoma	0.000578	0.0058	CcSEcCtD
Desipramine—Neuropathy peripheral—Temozolomide—melanoma	0.000574	0.00576	CcSEcCtD
Desipramine—Stomatitis—Temozolomide—melanoma	0.000571	0.00573	CcSEcCtD
Desipramine—SLC22A4—neck—melanoma	0.000569	0.0358	CbGeAlD
Desipramine—Alopecia—Bleomycin—melanoma	0.000551	0.00553	CcSEcCtD
Desipramine—Hypoaesthesia—Carmustine—melanoma	0.000542	0.00544	CcSEcCtD
Desipramine—Hallucination—Carmustine—melanoma	0.000542	0.00544	CcSEcCtD
Desipramine—Flushing—Dactinomycin—melanoma	0.00054	0.00542	CcSEcCtD
Desipramine—Hepatitis—Temozolomide—melanoma	0.000526	0.00528	CcSEcCtD
Desipramine—Asthenia—Vemurafenib—melanoma	0.000525	0.00527	CcSEcCtD
Desipramine—Hallucination—Temozolomide—melanoma	0.000523	0.00525	CcSEcCtD
Desipramine—Hypoaesthesia—Temozolomide—melanoma	0.000523	0.00525	CcSEcCtD
Desipramine—CHRM5—skin of body—melanoma	0.00052	0.0327	CbGeAlD
Desipramine—Pruritus—Vemurafenib—melanoma	0.000517	0.00519	CcSEcCtD
Desipramine—Alopecia—Dactinomycin—melanoma	0.000514	0.00516	CcSEcCtD
Desipramine—SMPD1—head—melanoma	0.00051	0.0321	CbGeAlD
Desipramine—Flushing—Carmustine—melanoma	0.000505	0.00507	CcSEcCtD
Desipramine—Ill-defined disorder—Bleomycin—melanoma	0.000504	0.00505	CcSEcCtD
Desipramine—Diarrhoea—Vemurafenib—melanoma	0.0005	0.00502	CcSEcCtD
Desipramine—Tinnitus—Temozolomide—melanoma	0.00049	0.00492	CcSEcCtD
Desipramine—Malaise—Bleomycin—melanoma	0.000489	0.00491	CcSEcCtD
Desipramine—Flushing—Temozolomide—melanoma	0.000488	0.0049	CcSEcCtD
Desipramine—Arrhythmia—Carmustine—melanoma	0.000486	0.00488	CcSEcCtD
Desipramine—Dizziness—Vemurafenib—melanoma	0.000484	0.00485	CcSEcCtD
Desipramine—Alopecia—Carmustine—melanoma	0.000481	0.00483	CcSEcCtD
Desipramine—Ataxia—Docetaxel—melanoma	0.000475	0.00477	CcSEcCtD
Desipramine—Ill-defined disorder—Dactinomycin—melanoma	0.00047	0.00471	CcSEcCtD
Desipramine—Liver function test abnormal—Docetaxel—melanoma	0.000467	0.00469	CcSEcCtD
Desipramine—Vomiting—Vemurafenib—melanoma	0.000465	0.00467	CcSEcCtD
Desipramine—Alopecia—Temozolomide—melanoma	0.000465	0.00467	CcSEcCtD
Desipramine—Rash—Vemurafenib—melanoma	0.000461	0.00463	CcSEcCtD
Desipramine—Dermatitis—Vemurafenib—melanoma	0.000461	0.00462	CcSEcCtD
Desipramine—Headache—Vemurafenib—melanoma	0.000458	0.0046	CcSEcCtD
Desipramine—Discomfort—Bleomycin—melanoma	0.000457	0.00458	CcSEcCtD
Desipramine—Malaise—Dactinomycin—melanoma	0.000457	0.00458	CcSEcCtD
Desipramine—Dysgeusia—Temozolomide—melanoma	0.000448	0.0045	CcSEcCtD
Desipramine—Confusional state—Bleomycin—melanoma	0.000447	0.00448	CcSEcCtD
Desipramine—Vision blurred—Carmustine—melanoma	0.000447	0.00448	CcSEcCtD
Desipramine—Tremor—Carmustine—melanoma	0.000444	0.00446	CcSEcCtD
Desipramine—Oedema—Bleomycin—melanoma	0.000443	0.00445	CcSEcCtD
Desipramine—Agitation—Carmustine—melanoma	0.000435	0.00437	CcSEcCtD
Desipramine—CHRM4—head—melanoma	0.000434	0.0273	CbGeAlD
Desipramine—Nausea—Vemurafenib—melanoma	0.000434	0.00436	CcSEcCtD
Desipramine—Thrombocytopenia—Bleomycin—melanoma	0.000434	0.00435	CcSEcCtD
Desipramine—Vision blurred—Temozolomide—melanoma	0.000432	0.00433	CcSEcCtD
Desipramine—Tremor—Temozolomide—melanoma	0.000429	0.00431	CcSEcCtD
Desipramine—Discomfort—Dactinomycin—melanoma	0.000426	0.00427	CcSEcCtD
Desipramine—Ill-defined disorder—Temozolomide—melanoma	0.000425	0.00426	CcSEcCtD
Desipramine—Anorexia—Bleomycin—melanoma	0.000422	0.00424	CcSEcCtD
Desipramine—Agitation—Temozolomide—melanoma	0.000421	0.00422	CcSEcCtD
Desipramine—Hypotension—Bleomycin—melanoma	0.000414	0.00415	CcSEcCtD
Desipramine—Oedema—Dactinomycin—melanoma	0.000413	0.00415	CcSEcCtD
Desipramine—Malaise—Temozolomide—melanoma	0.000413	0.00414	CcSEcCtD
Desipramine—Convulsion—Carmustine—melanoma	0.000411	0.00412	CcSEcCtD
Desipramine—Hypertension—Carmustine—melanoma	0.000409	0.00411	CcSEcCtD
Desipramine—Palpitations—Temozolomide—melanoma	0.000405	0.00406	CcSEcCtD
Desipramine—Thrombocytopenia—Dactinomycin—melanoma	0.000405	0.00406	CcSEcCtD
Desipramine—HTR2A—endothelium—melanoma	0.000404	0.0254	CbGeAlD
Desipramine—Anxiety—Carmustine—melanoma	0.000402	0.00403	CcSEcCtD
Desipramine—Paraesthesia—Bleomycin—melanoma	0.000398	0.00399	CcSEcCtD
Desipramine—Weight increased—Docetaxel—melanoma	0.000398	0.00399	CcSEcCtD
Desipramine—Convulsion—Temozolomide—melanoma	0.000397	0.00398	CcSEcCtD
Desipramine—Hypertension—Temozolomide—melanoma	0.000395	0.00397	CcSEcCtD
Desipramine—Anorexia—Dactinomycin—melanoma	0.000394	0.00395	CcSEcCtD
Desipramine—Confusional state—Carmustine—melanoma	0.00039	0.00391	CcSEcCtD
Desipramine—Anxiety—Temozolomide—melanoma	0.000388	0.0039	CcSEcCtD
Desipramine—Oedema—Carmustine—melanoma	0.000387	0.00388	CcSEcCtD
Desipramine—Discomfort—Temozolomide—melanoma	0.000385	0.00387	CcSEcCtD
Desipramine—Decreased appetite—Bleomycin—melanoma	0.000385	0.00387	CcSEcCtD
Desipramine—Acute coronary syndrome—Docetaxel—melanoma	0.000384	0.00386	CcSEcCtD
Desipramine—Myocardial infarction—Docetaxel—melanoma	0.000382	0.00383	CcSEcCtD
Desipramine—Neuropathy peripheral—Docetaxel—melanoma	0.000382	0.00383	CcSEcCtD
Desipramine—Dry mouth—Temozolomide—melanoma	0.000381	0.00383	CcSEcCtD
Desipramine—Stomatitis—Docetaxel—melanoma	0.00038	0.00381	CcSEcCtD
Desipramine—Jaundice—Docetaxel—melanoma	0.00038	0.00381	CcSEcCtD
Desipramine—Thrombocytopenia—Carmustine—melanoma	0.000379	0.0038	CcSEcCtD
Desipramine—Tachycardia—Carmustine—melanoma	0.000377	0.00379	CcSEcCtD
Desipramine—Confusional state—Temozolomide—melanoma	0.000377	0.00378	CcSEcCtD
Desipramine—Oedema—Temozolomide—melanoma	0.000374	0.00375	CcSEcCtD
Desipramine—HTR2A—blood vessel—melanoma	0.000373	0.0235	CbGeAlD
Desipramine—Anorexia—Carmustine—melanoma	0.000369	0.0037	CcSEcCtD
Desipramine—Thrombocytopenia—Temozolomide—melanoma	0.000366	0.00367	CcSEcCtD
Desipramine—Feeling abnormal—Bleomycin—melanoma	0.000365	0.00366	CcSEcCtD
Desipramine—Agranulocytosis—Docetaxel—melanoma	0.000364	0.00365	CcSEcCtD
Desipramine—Hypotension—Carmustine—melanoma	0.000361	0.00363	CcSEcCtD
Desipramine—Decreased appetite—Dactinomycin—melanoma	0.000359	0.0036	CcSEcCtD
Desipramine—SMPD1—lymph node—melanoma	0.000357	0.0225	CbGeAlD
Desipramine—Fatigue—Dactinomycin—melanoma	0.000356	0.00358	CcSEcCtD
Desipramine—Anorexia—Temozolomide—melanoma	0.000356	0.00358	CcSEcCtD
Desipramine—Urticaria—Bleomycin—melanoma	0.000352	0.00353	CcSEcCtD
Desipramine—Body temperature increased—Bleomycin—melanoma	0.00035	0.00351	CcSEcCtD
Desipramine—Hepatitis—Docetaxel—melanoma	0.00035	0.00351	CcSEcCtD
Desipramine—Insomnia—Carmustine—melanoma	0.00035	0.00351	CcSEcCtD
Desipramine—Hypoaesthesia—Docetaxel—melanoma	0.000348	0.00349	CcSEcCtD
Desipramine—Paraesthesia—Carmustine—melanoma	0.000347	0.00349	CcSEcCtD
Desipramine—Somnolence—Carmustine—melanoma	0.000344	0.00345	CcSEcCtD
Desipramine—Feeling abnormal—Dactinomycin—melanoma	0.00034	0.00342	CcSEcCtD
Desipramine—CHRM5—head—melanoma	0.000339	0.0214	CbGeAlD
Desipramine—Insomnia—Temozolomide—melanoma	0.000338	0.00339	CcSEcCtD
Desipramine—Decreased appetite—Carmustine—melanoma	0.000336	0.00337	CcSEcCtD
Desipramine—Paraesthesia—Temozolomide—melanoma	0.000336	0.00337	CcSEcCtD
Desipramine—Somnolence—Temozolomide—melanoma	0.000332	0.00333	CcSEcCtD
Desipramine—Constipation—Carmustine—melanoma	0.000331	0.00332	CcSEcCtD
Desipramine—Dyspepsia—Temozolomide—melanoma	0.000329	0.0033	CcSEcCtD
Desipramine—Body temperature increased—Dactinomycin—melanoma	0.000327	0.00328	CcSEcCtD
Desipramine—Abdominal pain—Dactinomycin—melanoma	0.000327	0.00328	CcSEcCtD
Desipramine—Decreased appetite—Temozolomide—melanoma	0.000325	0.00326	CcSEcCtD
Desipramine—Flushing—Docetaxel—melanoma	0.000325	0.00326	CcSEcCtD
Desipramine—Fatigue—Temozolomide—melanoma	0.000322	0.00323	CcSEcCtD
Desipramine—Constipation—Temozolomide—melanoma	0.00032	0.00321	CcSEcCtD
Desipramine—Feeling abnormal—Carmustine—melanoma	0.000319	0.0032	CcSEcCtD
Desipramine—Asthenia—Bleomycin—melanoma	0.000318	0.00319	CcSEcCtD
Desipramine—Pruritus—Bleomycin—melanoma	0.000313	0.00315	CcSEcCtD
Desipramine—Arrhythmia—Docetaxel—melanoma	0.000312	0.00314	CcSEcCtD
Desipramine—Alopecia—Docetaxel—melanoma	0.000309	0.0031	CcSEcCtD
Desipramine—Feeling abnormal—Temozolomide—melanoma	0.000308	0.00309	CcSEcCtD
Desipramine—SLC22A3—mammalian vulva—melanoma	0.000306	0.0192	CbGeAlD
Desipramine—Body temperature increased—Carmustine—melanoma	0.000306	0.00307	CcSEcCtD
Desipramine—Abdominal pain—Carmustine—melanoma	0.000306	0.00307	CcSEcCtD
Desipramine—DRD2—eye—melanoma	0.000301	0.0189	CbGeAlD
Desipramine—DRD2—retina—melanoma	0.000298	0.0188	CbGeAlD
Desipramine—Dysgeusia—Docetaxel—melanoma	0.000298	0.00299	CcSEcCtD
Desipramine—Urticaria—Temozolomide—melanoma	0.000297	0.00298	CcSEcCtD
Desipramine—Asthenia—Dactinomycin—melanoma	0.000296	0.00298	CcSEcCtD
Desipramine—Abdominal pain—Temozolomide—melanoma	0.000295	0.00296	CcSEcCtD
Desipramine—Body temperature increased—Temozolomide—melanoma	0.000295	0.00296	CcSEcCtD
Desipramine—Diarrhoea—Dactinomycin—melanoma	0.000283	0.00284	CcSEcCtD
Desipramine—Vomiting—Bleomycin—melanoma	0.000282	0.00283	CcSEcCtD
Desipramine—Rash—Bleomycin—melanoma	0.000279	0.0028	CcSEcCtD
Desipramine—Dermatitis—Bleomycin—melanoma	0.000279	0.0028	CcSEcCtD
Desipramine—SLC22A5—retina—melanoma	0.000278	0.0175	CbGeAlD
Desipramine—Asthenia—Carmustine—melanoma	0.000277	0.00278	CcSEcCtD
Desipramine—Palpitations—Docetaxel—melanoma	0.000269	0.0027	CcSEcCtD
Desipramine—Asthenia—Temozolomide—melanoma	0.000268	0.00269	CcSEcCtD
Desipramine—HTR2A—neck—melanoma	0.000267	0.0168	CbGeAlD
Desipramine—Diarrhoea—Carmustine—melanoma	0.000265	0.00266	CcSEcCtD
Desipramine—Pruritus—Temozolomide—melanoma	0.000264	0.00265	CcSEcCtD
Desipramine—Convulsion—Docetaxel—melanoma	0.000264	0.00265	CcSEcCtD
Desipramine—Nausea—Bleomycin—melanoma	0.000263	0.00264	CcSEcCtD
Desipramine—Hypertension—Docetaxel—melanoma	0.000263	0.00264	CcSEcCtD
Desipramine—Vomiting—Dactinomycin—melanoma	0.000263	0.00264	CcSEcCtD
Desipramine—Rash—Dactinomycin—melanoma	0.00026	0.00261	CcSEcCtD
Desipramine—Dizziness—Carmustine—melanoma	0.000256	0.00257	CcSEcCtD
Desipramine—Diarrhoea—Temozolomide—melanoma	0.000256	0.00257	CcSEcCtD
Desipramine—Dry mouth—Docetaxel—melanoma	0.000254	0.00254	CcSEcCtD
Desipramine—Confusional state—Docetaxel—melanoma	0.000251	0.00251	CcSEcCtD
Desipramine—Oedema—Docetaxel—melanoma	0.000248	0.00249	CcSEcCtD
Desipramine—Dizziness—Temozolomide—melanoma	0.000247	0.00248	CcSEcCtD
Desipramine—Vomiting—Carmustine—melanoma	0.000246	0.00247	CcSEcCtD
Desipramine—Nausea—Dactinomycin—melanoma	0.000245	0.00246	CcSEcCtD
Desipramine—ABCB1—blood vessel—melanoma	0.000244	0.0154	CbGeAlD
Desipramine—Rash—Carmustine—melanoma	0.000244	0.00245	CcSEcCtD
Desipramine—SLC22A5—skin of body—melanoma	0.000244	0.0153	CbGeAlD
Desipramine—Dermatitis—Carmustine—melanoma	0.000244	0.00244	CcSEcCtD
Desipramine—Thrombocytopenia—Docetaxel—melanoma	0.000243	0.00244	CcSEcCtD
Desipramine—Tachycardia—Docetaxel—melanoma	0.000243	0.00243	CcSEcCtD
Desipramine—Headache—Carmustine—melanoma	0.000242	0.00243	CcSEcCtD
Desipramine—HRH1—eye—melanoma	0.000238	0.0149	CbGeAlD
Desipramine—Vomiting—Temozolomide—melanoma	0.000238	0.00238	CcSEcCtD
Desipramine—Anorexia—Docetaxel—melanoma	0.000237	0.00238	CcSEcCtD
Desipramine—Rash—Temozolomide—melanoma	0.000236	0.00236	CcSEcCtD
Desipramine—Dermatitis—Temozolomide—melanoma	0.000235	0.00236	CcSEcCtD
Desipramine—Headache—Temozolomide—melanoma	0.000234	0.00235	CcSEcCtD
Desipramine—CHRM2—head—melanoma	0.000233	0.0147	CbGeAlD
Desipramine—SLC6A3—head—melanoma	0.000232	0.0146	CbGeAlD
Desipramine—Hypotension—Docetaxel—melanoma	0.000232	0.00233	CcSEcCtD
Desipramine—Nausea—Carmustine—melanoma	0.00023	0.00231	CcSEcCtD
Desipramine—SLC22A1—head—melanoma	0.000229	0.0144	CbGeAlD
Desipramine—Protriptyline—ABCB1—melanoma	0.000225	0.079	CrCbGaD
Desipramine—Insomnia—Docetaxel—melanoma	0.000225	0.00226	CcSEcCtD
Desipramine—HTR2C—head—melanoma	0.000225	0.0141	CbGeAlD
Desipramine—Paraesthesia—Docetaxel—melanoma	0.000223	0.00224	CcSEcCtD
Desipramine—Nausea—Temozolomide—melanoma	0.000222	0.00223	CcSEcCtD
Desipramine—Somnolence—Docetaxel—melanoma	0.000221	0.00222	CcSEcCtD
Desipramine—ADRB1—head—melanoma	0.00022	0.0139	CbGeAlD
Desipramine—SLC22A3—head—melanoma	0.000219	0.0138	CbGeAlD
Desipramine—Dyspepsia—Docetaxel—melanoma	0.000219	0.0022	CcSEcCtD
Desipramine—Decreased appetite—Docetaxel—melanoma	0.000216	0.00217	CcSEcCtD
Desipramine—Fatigue—Docetaxel—melanoma	0.000214	0.00215	CcSEcCtD
Desipramine—SLC6A4—head—melanoma	0.000213	0.0134	CbGeAlD
Desipramine—Constipation—Docetaxel—melanoma	0.000213	0.00213	CcSEcCtD
Desipramine—CHRM1—head—melanoma	0.000212	0.0133	CbGeAlD
Desipramine—CYP2B6—skin of body—melanoma	0.000212	0.0133	CbGeAlD
Desipramine—Feeling abnormal—Docetaxel—melanoma	0.000205	0.00206	CcSEcCtD
Desipramine—HTR2A—eye—melanoma	0.000198	0.0125	CbGeAlD
Desipramine—HTR2A—retina—melanoma	0.000197	0.0124	CbGeAlD
Desipramine—Abdominal pain—Docetaxel—melanoma	0.000196	0.00197	CcSEcCtD
Desipramine—Body temperature increased—Docetaxel—melanoma	0.000196	0.00197	CcSEcCtD
Desipramine—CHRM3—head—melanoma	0.00019	0.0119	CbGeAlD
Desipramine—HTR1A—head—melanoma	0.000189	0.0119	CbGeAlD
Desipramine—HRH1—mammalian vulva—melanoma	0.000189	0.0119	CbGeAlD
Desipramine—SLC6A2—head—melanoma	0.000187	0.0118	CbGeAlD
Desipramine—Asthenia—Docetaxel—melanoma	0.000178	0.00179	CcSEcCtD
Desipramine—Pruritus—Docetaxel—melanoma	0.000176	0.00176	CcSEcCtD
Desipramine—ORM1—lymph node—melanoma	0.000175	0.011	CbGeAlD
Desipramine—DRD2—head—melanoma	0.000171	0.0107	CbGeAlD
Desipramine—Diarrhoea—Docetaxel—melanoma	0.00017	0.00171	CcSEcCtD
Desipramine—SLC22A4—lymph node—melanoma	0.000168	0.0106	CbGeAlD
Desipramine—Epinastine—ABCB1—melanoma	0.000167	0.0586	CrCbGaD
Desipramine—Dizziness—Docetaxel—melanoma	0.000164	0.00165	CcSEcCtD
Desipramine—Oxcarbazepine—ALB—melanoma	0.000161	0.0566	CrCbGaD
Desipramine—Vomiting—Docetaxel—melanoma	0.000158	0.00159	CcSEcCtD
Desipramine—Rash—Docetaxel—melanoma	0.000157	0.00157	CcSEcCtD
Desipramine—Dermatitis—Docetaxel—melanoma	0.000157	0.00157	CcSEcCtD
Desipramine—Headache—Docetaxel—melanoma	0.000156	0.00156	CcSEcCtD
Desipramine—SLC22A3—lymph node—melanoma	0.000153	0.00964	CbGeAlD
Desipramine—Nausea—Docetaxel—melanoma	0.000148	0.00148	CcSEcCtD
Desipramine—Maprotiline—ABCB1—melanoma	0.000144	0.0504	CrCbGaD
Desipramine—CYP2B6—head—melanoma	0.000138	0.00869	CbGeAlD
Desipramine—HRH1—head—melanoma	0.000135	0.00849	CbGeAlD
Desipramine—SLC6A2—lymph node—melanoma	0.000131	0.00826	CbGeAlD
Desipramine—CYP2E1—head—melanoma	0.00013	0.00815	CbGeAlD
Desipramine—ABCB1—retina—melanoma	0.000129	0.00811	CbGeAlD
Desipramine—Triflupromazine—ABCB1—melanoma	0.000125	0.0441	CrCbGaD
Desipramine—Acepromazine—ALB—melanoma	0.000122	0.0427	CrCbGaD
Desipramine—HTR2A—head—melanoma	0.000113	0.00709	CbGeAlD
Desipramine—SLC22A5—lymph node—melanoma	0.000111	0.00701	CbGeAlD
Desipramine—Carbamazepine—ABCB1—melanoma	0.000105	0.0368	CrCbGaD
Desipramine—ABCB1—mammalian vulva—melanoma	0.000103	0.00649	CbGeAlD
Desipramine—CYP2D6—head—melanoma	0.000103	0.00646	CbGeAlD
Desipramine—HRH1—lymph node—melanoma	9.45e-05	0.00594	CbGeAlD
Desipramine—Clomipramine—ALB—melanoma	9.25e-05	0.0325	CrCbGaD
Desipramine—Nortriptyline—ALB—melanoma	9.04e-05	0.0317	CrCbGaD
Desipramine—Clomipramine—ABCB1—melanoma	8.83e-05	0.031	CrCbGaD
Desipramine—Trimipramine—ABCB1—melanoma	8.12e-05	0.0285	CrCbGaD
Desipramine—Promethazine—ABCB1—melanoma	7.82e-05	0.0275	CrCbGaD
Desipramine—Doxepin—ABCB1—melanoma	7.74e-05	0.0272	CrCbGaD
Desipramine—ABCB1—head—melanoma	7.38e-05	0.00464	CbGeAlD
Desipramine—Chlorpromazine—ALB—melanoma	6.34e-05	0.0223	CrCbGaD
Desipramine—Amitriptyline—ALB—melanoma	6.27e-05	0.022	CrCbGaD
Desipramine—Chlorpromazine—ABCB1—melanoma	6.05e-05	0.0213	CrCbGaD
Desipramine—Imipramine—ABCB1—melanoma	6.02e-05	0.0212	CrCbGaD
Desipramine—Amitriptyline—ABCB1—melanoma	5.99e-05	0.021	CrCbGaD
Desipramine—ABCB1—lymph node—melanoma	5.17e-05	0.00325	CbGeAlD
Desipramine—HRH1—Signaling Pathways—CASP3—melanoma	3.19e-06	1.76e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL2—melanoma	3.19e-06	1.76e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—STAT3—melanoma	3.18e-06	1.75e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CASP3—melanoma	3.18e-06	1.75e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—IL6—melanoma	3.18e-06	1.75e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL2—melanoma	3.18e-06	1.75e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—melanoma	3.17e-06	1.75e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CASP3—melanoma	3.17e-06	1.75e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—IL6—melanoma	3.17e-06	1.75e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—melanoma	3.17e-06	1.75e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL2—melanoma	3.17e-06	1.74e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CCND1—melanoma	3.16e-06	1.74e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—IL6—melanoma	3.16e-06	1.74e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—IL6—melanoma	3.15e-06	1.74e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—melanoma	3.14e-06	1.73e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CASP3—melanoma	3.14e-06	1.73e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL2—melanoma	3.13e-06	1.73e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—melanoma	3.13e-06	1.73e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—melanoma	3.13e-06	1.72e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—melanoma	3.12e-06	1.72e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—IL6—melanoma	3.12e-06	1.72e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CCND1—melanoma	3.11e-06	1.72e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—STAT3—melanoma	3.11e-06	1.71e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK3—melanoma	3.11e-06	1.71e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CCND1—melanoma	3.11e-06	1.71e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PPARG—melanoma	3.1e-06	1.71e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—melanoma	3.1e-06	1.71e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CCND1—melanoma	3.1e-06	1.71e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—STAT3—melanoma	3.09e-06	1.71e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—melanoma	3.09e-06	1.7e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CCND1—melanoma	3.09e-06	1.7e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—melanoma	3.08e-06	1.7e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CD—melanoma	3.07e-06	1.69e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MMP9—melanoma	3.07e-06	1.69e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—melanoma	3.07e-06	1.69e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—melanoma	3.06e-06	1.69e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1A—melanoma	3.06e-06	1.69e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CCND1—melanoma	3.06e-06	1.68e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—melanoma	3.06e-06	1.68e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—melanoma	3.05e-06	1.68e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK3—melanoma	3.04e-06	1.67e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NFKB1—melanoma	3.04e-06	1.67e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—ALB—melanoma	3.03e-06	1.67e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—melanoma	3.03e-06	1.67e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—melanoma	3.02e-06	1.67e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MMP9—melanoma	3.02e-06	1.67e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MYC—melanoma	3.02e-06	1.67e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MMP9—melanoma	3.01e-06	1.66e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1A—melanoma	3.01e-06	1.66e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MMP9—melanoma	3.01e-06	1.66e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1A—melanoma	3e-06	1.66e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—melanoma	3e-06	1.66e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—melanoma	3e-06	1.65e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CD—melanoma	3e-06	1.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—melanoma	3e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MMP9—melanoma	3e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1A—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NFKB1—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—melanoma	2.99e-06	1.65e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1A—melanoma	2.98e-06	1.65e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NFKB1—melanoma	2.98e-06	1.64e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—melanoma	2.98e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—melanoma	2.98e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NFKB1—melanoma	2.97e-06	1.64e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK3—melanoma	2.97e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MMP9—melanoma	2.97e-06	1.64e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NFKB1—melanoma	2.96e-06	1.63e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—ALB—melanoma	2.96e-06	1.63e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1A—melanoma	2.96e-06	1.63e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK3—melanoma	2.96e-06	1.63e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—MAPK1—melanoma	2.96e-06	1.63e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MYC—melanoma	2.95e-06	1.63e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EGFR—melanoma	2.95e-06	1.63e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—melanoma	2.95e-06	1.63e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NFKB1—melanoma	2.94e-06	1.62e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—melanoma	2.93e-06	1.62e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—melanoma	2.92e-06	1.61e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—melanoma	2.92e-06	1.61e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ABCB1—melanoma	2.92e-06	1.61e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—melanoma	2.91e-06	1.61e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—melanoma	2.91e-06	1.6e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—melanoma	2.9e-06	1.6e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—melanoma	2.89e-06	1.59e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—MAPK1—melanoma	2.89e-06	1.59e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EGFR—melanoma	2.89e-06	1.59e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MYC—melanoma	2.89e-06	1.59e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—melanoma	2.88e-06	1.59e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MYC—melanoma	2.87e-06	1.58e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.86e-06	1.58e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CD—melanoma	2.83e-06	1.56e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—MAPK1—melanoma	2.83e-06	1.56e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EGFR—melanoma	2.83e-06	1.56e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—MAPK1—melanoma	2.81e-06	1.55e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EGFR—melanoma	2.81e-06	1.55e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—melanoma	2.79e-06	1.54e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—ALB—melanoma	2.79e-06	1.54e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—melanoma	2.77e-06	1.53e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—IL6—melanoma	2.77e-06	1.53e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—melanoma	2.76e-06	1.52e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—melanoma	2.73e-06	1.5e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—STAT3—melanoma	2.73e-06	1.5e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CG—melanoma	2.72e-06	1.5e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—melanoma	2.72e-06	1.5e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—melanoma	2.72e-06	1.5e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—melanoma	2.71e-06	1.5e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—melanoma	2.71e-06	1.49e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—melanoma	2.7e-06	1.49e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—melanoma	2.69e-06	1.48e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—STAT3—melanoma	2.69e-06	1.48e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PRKCA—melanoma	2.68e-06	1.48e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—STAT3—melanoma	2.68e-06	1.48e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—melanoma	2.68e-06	1.48e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CB—melanoma	2.68e-06	1.48e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—melanoma	2.68e-06	1.48e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—melanoma	2.67e-06	1.47e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—STAT3—melanoma	2.67e-06	1.47e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—melanoma	2.67e-06	1.47e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—melanoma	2.67e-06	1.47e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—melanoma	2.66e-06	1.47e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—STAT3—melanoma	2.66e-06	1.47e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ERCC2—melanoma	2.66e-06	1.47e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—melanoma	2.66e-06	1.46e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—melanoma	2.66e-06	1.46e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTGS2—melanoma	2.65e-06	1.46e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—IL6—melanoma	2.65e-06	1.46e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—STAT3—melanoma	2.64e-06	1.45e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—melanoma	2.63e-06	1.45e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PPARG—melanoma	2.63e-06	1.45e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CB—melanoma	2.62e-06	1.44e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK3—melanoma	2.61e-06	1.44e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTGS2—melanoma	2.59e-06	1.43e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK3—melanoma	2.57e-06	1.41e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—melanoma	2.56e-06	1.41e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK3—melanoma	2.56e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—melanoma	2.55e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK3—melanoma	2.55e-06	1.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK3—melanoma	2.54e-06	1.4e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MYC—melanoma	2.54e-06	1.4e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK3—melanoma	2.52e-06	1.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—melanoma	2.51e-06	1.38e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—melanoma	2.51e-06	1.38e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MYC—melanoma	2.5e-06	1.38e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MYC—melanoma	2.49e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MYC—melanoma	2.48e-06	1.37e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—MAPK1—melanoma	2.48e-06	1.37e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EGFR—melanoma	2.48e-06	1.37e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—melanoma	2.48e-06	1.37e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MYC—melanoma	2.47e-06	1.36e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CB—melanoma	2.46e-06	1.36e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—melanoma	2.45e-06	1.35e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MYC—melanoma	2.45e-06	1.35e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—melanoma	2.45e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—MAPK1—melanoma	2.44e-06	1.35e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTGS2—melanoma	2.44e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EGFR—melanoma	2.44e-06	1.35e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—melanoma	2.44e-06	1.35e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—MAPK1—melanoma	2.44e-06	1.34e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EGFR—melanoma	2.44e-06	1.34e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—MAPK1—melanoma	2.43e-06	1.34e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EGFR—melanoma	2.43e-06	1.34e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—melanoma	2.43e-06	1.34e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—MAPK1—melanoma	2.42e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EGFR—melanoma	2.42e-06	1.33e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—MAPK1—melanoma	2.4e-06	1.32e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EGFR—melanoma	2.4e-06	1.32e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CD—melanoma	2.4e-06	1.32e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—melanoma	2.38e-06	1.31e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—melanoma	2.37e-06	1.31e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—melanoma	2.37e-06	1.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—ALB—melanoma	2.36e-06	1.3e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—melanoma	2.36e-06	1.3e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—melanoma	2.34e-06	1.29e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—melanoma	2.32e-06	1.28e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—melanoma	2.32e-06	1.28e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—melanoma	2.31e-06	1.27e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—melanoma	2.3e-06	1.27e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—melanoma	2.29e-06	1.26e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—melanoma	2.29e-06	1.26e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—IL6—melanoma	2.27e-06	1.25e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—melanoma	2.27e-06	1.25e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—melanoma	2.26e-06	1.25e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—melanoma	2.26e-06	1.25e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—melanoma	2.26e-06	1.24e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—melanoma	2.22e-06	1.22e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—IL6—melanoma	2.22e-06	1.22e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—melanoma	2.19e-06	1.21e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—IL6—melanoma	2.17e-06	1.2e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—melanoma	2.16e-06	1.19e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—IL6—melanoma	2.16e-06	1.19e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—melanoma	2.15e-06	1.19e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—melanoma	2.13e-06	1.17e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—melanoma	2.12e-06	1.17e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—melanoma	2.12e-06	1.17e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—melanoma	2.11e-06	1.17e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—melanoma	2.11e-06	1.16e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CG—melanoma	2.1e-06	1.16e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—melanoma	2.1e-06	1.16e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—melanoma	2.09e-06	1.15e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CB—melanoma	2.09e-06	1.15e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—melanoma	2.08e-06	1.15e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—melanoma	2.08e-06	1.15e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTGS2—melanoma	2.07e-06	1.14e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—melanoma	2.05e-06	1.13e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—melanoma	2.05e-06	1.13e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—melanoma	2.05e-06	1.13e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—melanoma	2.05e-06	1.13e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—melanoma	2.04e-06	1.12e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—melanoma	2.03e-06	1.12e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PPARG—melanoma	2.03e-06	1.12e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—melanoma	2.01e-06	1.11e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—melanoma	2e-06	1.1e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—melanoma	1.99e-06	1.1e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—melanoma	1.99e-06	1.1e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—melanoma	1.96e-06	1.08e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—melanoma	1.96e-06	1.08e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—melanoma	1.95e-06	1.07e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—melanoma	1.94e-06	1.07e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—melanoma	1.92e-06	1.06e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—IL6—melanoma	1.91e-06	1.05e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—IL6—melanoma	1.88e-06	1.03e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—IL6—melanoma	1.87e-06	1.03e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—IL6—melanoma	1.87e-06	1.03e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—IL6—melanoma	1.86e-06	1.03e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CD—melanoma	1.85e-06	1.02e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—IL6—melanoma	1.84e-06	1.02e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—ALB—melanoma	1.82e-06	1.01e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—melanoma	1.8e-06	9.94e-06	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—melanoma	1.77e-06	9.73e-06	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—melanoma	1.76e-06	9.7e-06	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—melanoma	1.73e-06	9.54e-06	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—melanoma	1.73e-06	9.53e-06	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—melanoma	1.73e-06	9.52e-06	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—melanoma	1.72e-06	9.49e-06	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—melanoma	1.72e-06	9.46e-06	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—melanoma	1.7e-06	9.37e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—melanoma	1.63e-06	9e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CB—melanoma	1.61e-06	8.88e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTGS2—melanoma	1.6e-06	8.8e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—melanoma	1.59e-06	8.79e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—melanoma	1.5e-06	8.28e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—melanoma	1.39e-06	7.67e-06	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—melanoma	1.33e-06	7.35e-06	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—melanoma	1.3e-06	7.18e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—melanoma	1.27e-06	7.02e-06	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—melanoma	1.23e-06	6.76e-06	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—melanoma	1.04e-06	5.73e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—melanoma	9.82e-07	5.41e-06	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—melanoma	8.02e-07	4.42e-06	CbGpPWpGaD
